What It Means To Be a Comprehensive Cancer Center
Health care providers often use the word “comprehensive” in marketing to attract patients to their institutions for cancer care. Yet the care provided at a cancer center designated by the National Cancer Institute with the “comprehensive” status indicates a breadth and depth not offered in most hospitals. John L. Marshall, MD, chief medical officer of Lombardi Comprehensive Cancer Center sheds some light on what “comprehensive” means.

What is a True Comprehensive Cancer Center?
Obviously, any organization can use the word “comprehensive” to describe the services they offer. But when it comes to cancer care, it’s important to understand what comprehensive truly means. The “comprehensive” in our name is not just a word. It is validation from the National Cancer Institute (NCI) that our cancer center has proven excellence, leadership and resources, in addition to a superior demonstration of laboratory and clinical research. Also, a comprehensive cancer center like ours is a part of the community we serve — a critical part of our mission is providing programs and services tailored to what our community needs.
Lombardi Comprehensive Cancer Center first received its Comprehensive Cancer Center designation 50 years ago, and it remains the only such cancer center in Washington, DC, and one of only 56 Comprehensive Cancer Centers in the country. The NCI reviews cancer centers about every five years to ensure they continuously meet the exceptionally high standards required to maintain the “comprehensive” status. That means the NCI recognizes that our leadership and resources are best positioned to provide excellent, high-impact laboratory and clinical research. Simply put, we have met rigorous standards “for transdisciplinary, state-of-the-art research focused on developing new and better approaches to preventing, diagnosing, and treating cancer.”
How Does the Distinction Make a Difference for Patients?
It translates into the best possible care for patients. When treated as part of an NCI-designated Comprehensive Cancer Center like Georgetown Lombardi in collaboration with the specialists of the MedStar Georgetown Cancer Institute network, patients have access to innovative clinical research, exceptional patient care, and advanced technology.
It signifies a multidisciplinary approach to cancer care. We serve as a central hub for all our patients’ needs, offering a full spectrum of cancer services, including screening and prevention, research, diagnosis, treatment, rehabilitation, social/emotional support, and survivorship programs. Our specialists are leaders in the field of cancer research and work collaboratively to develop unique treatment plans designed specifically for each patient. Our oncology nurse navigators streamline the process, ensuring the delivery of patient-centered care throughout the cancer journey. This team approach results in higher quality care and, ultimately, better outcomes.
Why Choose an NCI-Designated Comprehensive Cancer Center?
Centers like ours dedicate significant resources toward developing research programs, faculty and facilities that will lead to better and innovative approaches to cancer prevention, diagnosis, and treatment. In many cases, certain treatments and clinical trials are only available through NCI-designated Comprehensive Cancer Centers and their affiliates.
In addition, NCI supports the research infrastructure for cancer centers to advance scientific goals and foster cancer programs that draw together investigators from different disciplines. Our work has national and international reach, and we are constantly striving to advance our understanding of cancer and enhance treatments in collaboration with our partners and the greater cancer community.
-
What It Means To Be a Comprehensive Cancer Center
John L. Marshall, MD, chief medical officer of Georgetown Lombardi, explains what being treated at a “Comprehensive Cancer Center” means from a patient’s perspective.
Category: Special Stories
-
Ralph Lauren Center Marks Its First Year at Georgetown
Nearly one year after the opening of the Ralph Lauren Center for Cancer Prevention, Ralph Lauren leaders toured the center and received an update on its accomplishments from center leaders and staff.
Category: Lombardi Stories
-
Georgetown Lombardi Gala To Honor Washington Philanthropists, Cancer Advocates
Two cancer advocates and a pair of dedicated philanthropists will be honored at the 36th Annual Lombardi Gala, an annual event dedicated to raising funds for Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: News Release
-
Women’s History Month
Georgetown University kicks off Women's History month with a variety of events. Follow the full schedule of events to celebrate with a variety of local in-person to virtual options. A featured event
Category: CRTEC News
-
Black History Month Events at Georgetown
Explore the schedule of events in celebration of Black History Month.
Category: CRTEC News
-
Could a Georgetown Lab Finding Lead to New Treatment in Pancreatic Cancer?
For the first time, new research by Georgetown scientists shows potential to make immunotherapy effective in pancreatic cancer by combining it with a drug that makes cancer cells more responsive to immunotherapy. The research is now in a phase 2 clinical trial being tested in human patients.
Category: Lombardi Stories
-
Staying Hands-on in Hope: For the Future of Pediatric Cancer Research (and Maybe a New Car)
The Hyundai Hands On Hope contest, generously sponsored by the Washington Area Hyundai Dealers, ran January 19 to 21 and featured healthy competition between Georgetown Lombardi and Children’s National.
Category: Lombardi Stories
-
Understanding Immunotherapy Resistance Leads to New Therapeutic Strategies — and Hope
Samir Khleif, MD, an immunologist and professor of oncology at Georgetown Lombardi, is working to understand why some cancers become resistant to immunotherapy, and how that resistance can be overcome.
Category: Lombardi Stories
-
Georgetown Lombardi Faculty Members Aim To Improve Lung Cancer Screening and Smoking Cessation Rates by Focusing on Equity in Care
Kathryn Taylor, PhD, professor of oncology, believes she can have no greater impact on reducing the burden of cancer than by focusing on the harms of tobacco use. The work she co-leads with Randi Williams, PhD, assistant professor of oncology, as part of the Lung Screening, Tobacco, and Health (LSTH) research lab at Georgetown University’s Lombardi Comprehensive Cancer Center is especially impactful on underserved communities, who are often the target of tobacco product marketing.
Category: Lombardi Stories
-
Ruesch Center Symposium Focuses on Early-Onset GI Cancer
With an emphasis on early-onset gastrointestinal cancer, the 14th Annual Ruesch Center Symposium brought together nearly 300 health care providers, researchers, advocates, patients and caregivers November 16-18 to honor those dedicated to curing GI cancers, discuss the experiences of patients and caregivers, and share the latest research in the field.
Category: Lombardi Stories